Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Change in Cash: 2009-2025

Historic Change in Cash for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $10.4 million.

  • BIO-TECHNE's Change in Cash fell 148.18% to -$17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.6 million, marking a year-over-year decrease of 209.52%. This contributed to the annual value of $10.4 million for FY2025, which is 136.12% up from last year.
  • According to the latest figures from FY2025, BIO-TECHNE's Change in Cash is $10.4 million, which was up 136.12% from -$28.8 million recorded in FY2024.
  • BIO-TECHNE's 5-year Change in Cash high stood at $52.5 million for FY2021, and its period low was -$28.8 million during FY2024.
  • Its 3-year average for Change in Cash is -$3.5 million, with a median of $8.0 million in 2023.
  • Its Change in Cash has fluctuated over the past 5 years, first slumped by 459.57% in 2024, then surged by 136.12% in 2025.
  • Over the past 5 years, BIO-TECHNE's Change in Cash (Yearly) stood at $52.5 million in 2021, then tumbled by 150.55% to -$26.5 million in 2022, then soared by 130.18% to $8.0 million in 2023, then plummeted by 459.57% to -$28.8 million in 2024, then spiked by 136.12% to $10.4 million in 2025.